http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102007143-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-102 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-62 |
| filingDate | 2009-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102007143-B |
| titleOfInvention | There is the novel insulin derivates of super delayed aging feature |
| abstract | The present invention relates to the novel insulin analogs with basic Aging Characteristic, it is characterized by: a) B chain end is made up of amidated alkaline amino acid residue, as lysyl amine or arginine amide; B) INSULIN A chain N-terminal amino-acid residue is Methionin or arginine residues; C) A8 amino acid position is occupied by histidine residues; D) A21 amino acid position is occupied by glycine residue; E) on A5, A15, A18, B-1, B0, B1, B2, B3 and B4 position, realize one or more replacement of electronegative amino-acid residue and/or add. |
| priorityDate | 2008-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 216.